ArticleFrontiers in oncology2025

Efficacy of brentuximab vedotin combined with sintilimab in relapsed/refractory DLBCL patient with secondary hemophagocytic syndrome: a case report and literature review.

Siyu Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.